Latest Pharma and Biotech News
Biotechnology
28 November 2024 Johnson & Johnson has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies like CAR-T and bispecific antibodies. At the 2024 ASH meeting, J&J aims to showcase progress, with a goal of achieving a functional cure for multiple myeloma.
Today's issue
Refine Search
Biotechnology
Zug-based Galderma has published positive results from the Phase III OLYMPIA 1 trial in JAMA Dermatology, as the company’s newly-minted shares change hands in record volumes. 29 November 2024
Biotechnology
Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%. Toripalimab is a New Biological Entity (NBE), the company noted. 29 November 2024
Biotechnology
French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to bolster preparedness for emergencies, including potential pandemics, according to Bloomberg and other media reports. 29 November 2024
Biotechnology
During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian Oswaldo Cruz Foundation (Fiocruz) through its Institute of Technology on Immunobiologicals (Bio-Manguinhos), and the Belgian companies Quantoom Biosciences and Univercells. 29 November 2024
Biotechnology
PTC Therapeutics is to sell its rare pediatric disease priority review voucher (PRV) for $150 million. 28 November 2024
Biotechnology
A report from industry analyst DelveInsight highlights progress in the myotonic dystrophy treatment landscape, with more than 20 companies developing over 22 innovative treatments. 28 November 2024
Biotechnology
The UK subsidiary of Dutch drugmaker argenx confirmed today that its investigational therapy, subcutaneous efgartigimod alfa has been granted Promising Innovative Medicine (PIM) designation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 28 November 2024
Biotechnology
Privately-held French drugmaker Servier has announced the inauguration of its first unit dedicated to the production of biological medicines from its R&D pipeline. 28 November 2024
Biotechnology
The US Food and Drug Administration has received new reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), following treatment of early, active cerebral adrenoleukodystrophy (CALD) patients with Skysona (elivaldogene autotemcel). 28 November 2024
Biotechnology
San Diago, USA-based Acadia Pharmaceuticals yesterday announced it has entered into an exclusive worldwide license agreement with Denmark’s Saniona for the development and commercialization of SAN711, a first-in-class, highly selective GABAA-α3 positive allosteric modulator. 28 November 2024
Biotechnology
Kronos Bio, a biotech with a presence on the east and west coasts of the USA, has unveiled a major restructuring plan. 28 November 2024
Biotechnology
Johnson & Johnson has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies like CAR-T and bispecific antibodies. At the 2024 ASH meeting, J&J aims to showcase progress, with a goal of achieving a functional cure for multiple myeloma. 28 November 2024
Biotechnology
The European medicines regulator has approved a combo therapy starring PD-1 inhibitor Tevimbra (tislelizumab), from cancer firm BeOne Medicines, formerly BeiGene. 27 November 2024
Biotechnology
After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company that the supplemental New Drug Application (sNDA) for cabozantinib (Cabometyx) for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and advanced extra-pancreatic NET (epNET) will be discussed at an Oncologic Drugs Advisory Committee (ODAC) meeting in March 2025. 27 November 2024
Biotechnology
Chengdu-based Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed antibody-drug conjugate (ADC). 27 November 2024
Biotechnology
AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now raised more than $100 million in total, calls itself the leading platform for AI-powered protein engineering. 27 November 2024
Biotechnology
US clinical stage biotech Alector saw its shares tumble 35% to $2.57 by close of trading yesterday, as it announced disappointing results from the INVOKE-2 Phase II clinical trial evaluating the safety and efficacy of AL002 in slowing disease progression in individuals with early Alzheimer’s disease (AD). 27 November 2024
Biotechnology
PTC Therapeutics has announced that its Phase II trial for utreloxastat, aimed at treating amyotrophic lateral sclerosis (ALS), failed to meet its primary endpoint. 27 November 2024
Biotechnology
US companies Arrowhead Pharmaceuticals and Sarepta Therapeutics have announced a global licensing and collaboration agreement. 26 November 2024
Biotechnology
Clinical-stage US CAR-T therapies developer Poseida Therapeutics saw its shares skyrocket 227% to $9.36 pre-market today, on the news of a proposed takeover by Swiss pharma giant Roche. 26 November 2024
All news
Biotechnology
UK novel RNA therapeutics specialist Silence Therapeutics saw its sales rocket 32% to 535.00 pence as markets opened today, as it announced a strategic collaboration with AstraZeneca to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for cardiovascular, renal, metabolic and respiratory diseases. 25 March 2020
Biotechnology
As the world watches aghast, the novel coronavirus continues to spread its tentacles around the globe, with cases of COVID-19 rising to nearly 375,000 on Tuesday, an increase of 75,000 from the day before. 25 March 2020
Biotechnology
Austro-American company CEL-SCI Corporation and the University of Georgia’s (UGA) Center for Vaccines and Immunology have announced a collaboration in COVID-19. 24 March 2020
Biotechnology
Stock in Novavax rose more than 15% by early afternoon on Tuesday, after the US vaccine developer announced positive data for a Phase III clinical trial of NanoFlu. 24 March 2020
Biotechnology
Due to overwhelming demand, US biotech giant Gilead Sciences is temporarily stopping compassionate-use of its remdesivir, in order to focus supplies of the investigational antiviral for clinical testing as a possible treatment for the new coronavirus, COVID-19. 24 March 2020
Biotechnology
Belgian mRNA company eTheRNA Immunotherapies has announced that a consortium has been formed with North American and European partners to develop a vaccine against SARS-CoV-2 and preclinical development has started. 24 March 2020
Biotechnology
US drugmaker AbbVie is doing its bit to help in the COVID-19 crisis by giving up patent rights to a drug being studied for the virus. 24 March 2020
Biotechnology
Ireland-headquartered Ovoca Bio saw its shares gain more than 7% to 7.50 pence, after it announced an agreement to acquire the remaining shareholding in Russian biotech firm IVIX that the company does not already control. 24 March 2020
Biotechnology
Boston, USA-based biotech Pieris Pharmaceuticals has announced that its immuno-oncology collaboration with independent French drugmaker Servier is now to be focused on the two most advanced programs. 24 March 2020
Biotechnology
Data published at a virtual Clinical Trial Session, conducted by the Muscular Dystrophy Association (MDA), show Zolgensma (onasemnogene abeparvovec-xioi) produced significant benefit to people with spinal muscular atrophy (SMA). 24 March 2020
Biotechnology
A new Phase II/III trial into a potential COVID-19 treatment is being funded by the US Department of Health and Human Services (HHS). 24 March 2020
Biotechnology
South Korea's Celltrion Healthcare on Monday announced key milestones in its efforts to fight the 2019 novel coronavirus (COVID-19) pandemic. 24 March 2020
Biotechnology
Shares in Hoth Therapeutics were 90% higher after an hour’s trading on Monday. 23 March 2020
Biotechnology
US biopharma AbbVie today announced that the Phase III VIALE-A trial of (venetoclax) in combination with azacitidine versus azacitidine in combination with placebo met its dual primary endpoints. 23 March 2020
Biotechnology
As shares are falling around the world due to the coronavirus pandemic, those of Swiss clinical-stage biotech firm AC Immune were up 14.14% at $5.41 by mid-morning, after the company updated on its collaboration with Eli Lilly 23 March 2020
Biotechnology
Germany’s Bayer and Indian drug discovery firm Curadev Pvt Ltd today announced a research collaboration and license agreement for Curadev’s Stimulator of Interferon Genes (STING) antagonist program. 23 March 2020
Biotechnology
Initial data from a trial run by Oxford University spinout Vaccitech, together with the University of Oxford, show positive results for cancer candidate VTP-800. 23 March 2020
Biotechnology
UK biotech Synairgen saw its share leap more than 52% to 49.00 pence by close of trading on Friday, after it revealed it has received approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a Phase II trial of its lead product SNG001 (inhaled interferon-beta-1a) in coronavirus (COVID-19) patients. 21 March 2020
Biotechnology
Clinical-stage biotech Tarveda Therapeutics and China-owned SciClone Pharmaceuticals have entered into a licensing agreement for PEN-866, the initial clinical program from Tarveda’s HSP90 binding miniature drug conjugate platform. 20 March 2020
Biotechnology
The UK BioIndustry Association (BIA) has welcomed revised proposals put forward by the government to ensure that genuine biotech companies are not penalised by a cap on R&D tax credits. 20 March 2020
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze